Scarica l'app Stockscreener
182.77
1.86%
-3.46
Dopo l'orario di chiusura:
185.64
2.87
+1.57%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$186.23
Aprire:
$185.28
Volume 24 ore:
2.05M
Relative Volume:
0.83
Capitalizzazione di mercato:
$38.63B
Reddito:
$447.02M
Utile/perdita netta:
$-1.18B
Rapporto P/E:
-29.57
EPS:
-6.1812
Flusso di cassa netto:
$-868.57M
1 W Prestazione:
+10.58%
1M Prestazione:
+16.30%
6M Prestazione:
+152.79%
1 anno Prestazione:
+168.42%
Intervallo 1D:
$182.58
$187.88
Intervallo di 1 settimana:
$163.82
$197.08
Portata 52W:
$60.40
$197.08
Insmed Inc Stock (INSM) Company Profile
Nome
Insmed Inc
Settore
Industria
Telefono
908-977-9900
Indirizzo
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Confronta INSM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-28 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-10-20 | Iniziato | Wells Fargo | Overweight |
| 2025-08-20 | Iniziato | William Blair | Outperform |
| 2025-08-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Iniziato | Jefferies | Buy |
| 2025-02-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-04-23 | Iniziato | Truist | Buy |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-07-26 | Iniziato | Guggenheim | Buy |
| 2022-12-09 | Iniziato | Mizuho | Buy |
| 2022-12-07 | Iniziato | Barclays | Overweight |
| 2022-11-18 | Iniziato | BofA Securities | Buy |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2021-12-06 | Iniziato | JP Morgan | Overweight |
| 2021-10-19 | Ripresa | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-10-12 | Ripresa | Stifel | Buy |
| 2019-09-03 | Iniziato | Goldman | Buy |
| 2019-04-09 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-15 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-01-02 | Iniziato | Canaccord Genuity | Buy |
| 2018-08-06 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Iniziato | Goldman | Neutral |
| 2018-04-23 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Iniziato | Morgan Stanley | Overweight |
| 2018-01-18 | Iniziato | Credit Suisse | Neutral |
| 2017-09-05 | Reiterato | Evercore ISI | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-11 | Iniziato | Robert W. Baird | Outperform |
| 2016-03-15 | Iniziato | Stifel | Buy |
| 2015-11-09 | Downgrade | UBS | Buy → Neutral |
| 2015-10-06 | Reiterato | H.C. Wainwright | Buy |
| 2015-06-09 | Iniziato | Citigroup | Neutral |
| 2014-03-26 | Reiterato | HC Wainwright | Buy |
Mostra tutto
Insmed Inc Borsa (INSM) Ultime notizie
3,909 Shares in Insmed, Inc. $INSM Purchased by Corton Capital Inc. - MarketBeat
Why Insmed Incorporated is moving todayWeekly Stock Recap & Weekly Breakout Watchlists - newser.com
What dividend safety score for Insmed Incorporated stockTake Profit & Risk Adjusted Swing Trade Ideas - newser.com
Will Insmed Incorporated stock benefit from automationTrend Reversal & Stepwise Swing Trade Plans - newser.com
Trend analysis for Insmed Incorporated this week2025 Breakouts & Breakdowns & Technical Confirmation Alerts - newser.com
Can Insmed Incorporated stock deliver surprise earnings beatPortfolio Risk Summary & Fast Moving Trade Plans - newser.com
Assetmark Inc. Acquires 5,892 Shares of Insmed, Inc. $INSM - MarketBeat
Nisa Investment Advisors LLC Sells 1,556 Shares of Insmed, Inc. $INSM - MarketBeat
How Insmed Incorporated (IM8N) stock compares with tech leadersQuarterly Earnings Summary & Reliable Price Breakout Signals - newser.com
What machine learning models say about Insmed Incorporated2025 Investor Takeaways & Safe Investment Capital Preservation Plans - newser.com
What indicators show strength in Insmed Incorporated2025 Technical Overview & Free Weekly Watchlist of Top Performers - newser.com
Insmed Incorporated (INSM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Building trade automation scripts for Insmed IncorporatedBuy Signal & Technical Pattern Based Signals - newser.com
Approval of Brinsupri Lifted Insmed Incorporated (INSM) in Q3 - Yahoo Finance
Insmed discovers new cathepsin C inhibitors - BioWorld MedTech
Is Insmed Incorporated (IM8N) stock a buy before new product rollout2025 Market Outlook & Weekly High Momentum Picks - newser.com
Historical volatility pattern of Insmed Incorporated visualized2025 Historical Comparison & Stepwise Swing Trade Plans - newser.com
How Insmed Incorporated stock reacts to Fed rate cutsGap Down & Daily Profit Maximizing Tips - newser.com
Insmed Incorporated stock volume spike explainedJuly 2025 Volume & Fast Gain Swing Trade Alerts - newser.com
Earnings Beat: Insmed Incorporated (NASDAQ:INSM) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo Finance
Insmed, Inc. $INSM Position Reduced by Moody Aldrich Partners LLC - MarketBeat
Envestnet Asset Management Inc. Acquires 40,520 Shares of Insmed, Inc. $INSM - MarketBeat
Teacher Retirement System of Texas Has $4.93 Million Stake in Insmed, Inc. $INSM - MarketBeat
Insmed Incorporated (NASDAQ:INSM) Q3 2025 Earnings Call Transcript - Insider Monkey
Wells Fargo Maintains Insmed (INSM) Overweight Recommendation - Nasdaq
Insmed Inc (INSM) Stock Price, Trades & News - GuruFocus
Insmed (NASDAQ:INSM) Posts Earnings Results, Misses Estimates By $0.40 EPS - MarketBeat
Wells Fargo Raises Price Target for INSM to $217, Maintains Over - GuruFocus
Goldman Sachs Maintains Insmed (INSM) Buy Recommendation - Nasdaq
Wells Fargo Raises Price Target for INSM to $217, Maintains Overweight Rating | INSM Stock News - GuruFocus
Insmed (NASDAQ:INSM) Hits New 12-Month HighTime to Buy? - MarketBeat
Insmed Misses on Q3 Earnings, Stock Rises on Strong Brinsupri Uptake - sharewise.com
Goldman Sachs Boosts Insmed (INSM) Price Target to $225 | INSM Stock News - GuruFocus
INSM: UBS Maintains 'Buy', Raises Price Target to $223 | INSM St - GuruFocus
Insmed Shares Likely to Gain From Brinsupri Sales, Untapped Pipeline, UBS Says - MarketScreener
Insmed stock surges as UBS raises price target on Brinsupri launch success - Investing.com Canada
Insmed (INSM) Sees Price Target Raised by RBC Capital to $215 | - GuruFocus
Insmed (INSM) Hits All-Time High as Firm Posts Highly Optimistic Outlook - Insider Monkey
Insmed Q3 2025 slides reveal strong BRINSUPRI debut, ARIKAYCE growth accelerates - Investing.com Australia
Insmed stock hits 52-week high at 170.3 USD By Investing.com - Investing.com Australia
RBC Raises Price Target on Insmed to $215 From $139, Keeps Outperform Rating - MarketScreener
Cantor Fitzgerald Comments on Insmed FY2025 Earnings - MarketBeat
UBS Adjusts Insmed Price Target to $223 From $194, Maintains Buy Rating - MarketScreener
Truist Raises Price Target on Insmed to $214 From $139, Keeps Buy Rating - MarketScreener
Insmed: Q3 Earnings Snapshot - Stamford Advocate
Emerald Mutual Fund Advisers Trust Sells 328,407 Shares of Insmed, Inc. $INSM - MarketBeat
Emerald Advisers LLC Decreases Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed Reaches Analyst Target Price - Nasdaq
Insmed, Inc. $INSM Shares Sold by Jennison Associates LLC - MarketBeat
Biotech Stocks Hit 52-Week Highs: MTSR, INSM, ABVX, MAZE Lead October 30 Surge - RTTNews
Insmed Inc Azioni (INSM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Insmed Inc Azioni (INSM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Schaeffer Orlov S Nicole | Chief People Strategy Officer |
Sep 12 '25 |
Option Exercise |
23.75 |
56,520 |
1,342,350 |
112,981 |
| Schaeffer Orlov S Nicole | Chief People Strategy Officer |
Sep 12 '25 |
Sale |
145.45 |
76,520 |
11,129,927 |
36,461 |
| SHAROKY MELVIN MD | Director |
Sep 12 '25 |
Sale |
145.39 |
10,000 |
1,453,900 |
262,675 |
0.86%
0.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):